United States US: Prevalence of HIV: Total: % of Population Aged 15-49 data was reported at 0.500 % in 2014. This stayed constant from the previous number of 0.500 % for 2013. United States US: Prevalence of HIV: Total: % of Population Aged 15-49 data is updated yearly, averaging 0.500 % from Dec 2008 (Median) to 2014, with 7 observations. The data reached an all-time high of 0.500 % in 2014 and a record low of 0.500 % in 2014. United States US: Prevalence of HIV: Total: % of Population Aged 15-49 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Health Statistics. Prevalence of HIV refers to the percentage of people ages 15-49 who are infected with HIV.; ; UNAIDS estimates.; Weighted Average;

HIV/AIDS deaths in the U.S. have dropped significantly in recent years. In 1995, the death rate from HIV per 100,000 people was ****. That number has since decreased to *** per 100,000 as of 2023. The reduction in the HIV death rate in the U.S. can be attributed to an increase in access to HIV medications. HIV/AIDS in the U.S. Human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) cause a systemic viral infection that damages the immune system. AIDS is a syndrome that is caused by HIV. AIDS is when the immune system is severely weakened by HIV and the body can no longer fight off infections. Among all U.S. states, Georgia, followed by Florida and Louisiana, had the highest rates of new HIV diagnoses in 2022. HIV/AIDS treatments in the U.S. HIV/AIDS treatments include antiretroviral medications to reduce the levels of HIV within the body. The largest funders for HIV/AIDS medications and research are the National Institutes of Health (NIH) and the Ryan White Program. The top HIV drug worldwide, based on revenue generated in 2023 was Biktarvy. Around the world, access to antiretroviral treatment has increased dramatically in recent years, a huge step in reducing the number of HIV-related deaths. There is currently no cure for HIV.

United States US: Incidence of HIV: per 1,000 Uninfected Population data was reported at 0.110 Ratio in 2019. This stayed constant from the previous number of 0.110 Ratio for 2018. United States US: Incidence of HIV: per 1,000 Uninfected Population data is updated yearly, averaging 0.120 Ratio from Dec 2010 (Median) to 2019, with 10 observations. The data reached an all-time high of 0.130 Ratio in 2012 and a record low of 0.110 Ratio in 2019. United States US: Incidence of HIV: per 1,000 Uninfected Population data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s United States – Table US.World Bank.WDI: Social: Health Statistics. Number of new HIV infections among uninfected populations expressed per 1,000 uninfected population in the year before the period.;UNAIDS estimates.;Weighted average;This is the Sustainable Development Goal indicator 3.3.1 [https://unstats.un.org/sdgs/metadata/].

The states with the highest rates of HIV diagnoses in 2022 included Georgia, Louisiana, and Florida. However, the states with the highest number of people with HIV were Texas, California, and Florida. In Texas, there were around 4,896 people diagnosed with HIV. HIV/AIDS diagnoses In 2022, there were an estimated 38,043 new HIV diagnoses in the United States, a slight increase compared to the year before. Men account for the majority of these new diagnoses. There are currently around 1.2 million people living with HIV in the United States. Deaths from HIV The death rate from HIV has decreased significantly over the past few decades. In 2023, there were only 1.3 deaths from HIV per 100,000 population, the lowest rate since the epidemic began. However, the death rate varies greatly depending on race or ethnicity, with the death rate from HIV for African Americans reaching 19.2 per 100,000 population in 2022, compared to just three deaths per 100,000 among the white population.

United States US: Incidence of HIV: % of Uninfected Population Aged 15-49 data was reported at 0.020 % in 2014. This stayed constant from the previous number of 0.020 % for 2013. United States US: Incidence of HIV: % of Uninfected Population Aged 15-49 data is updated yearly, averaging 0.030 % from Dec 2008 (Median) to 2014, with 7 observations. The data reached an all-time high of 0.030 % in 2012 and a record low of 0.020 % in 2014. United States US: Incidence of HIV: % of Uninfected Population Aged 15-49 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Health Statistics. Number of new HIV infections among uninfected populations ages 15-49 expressed per 100 uninfected population in the year before the period.; ; UNAIDS estimates.; Weighted Average;

Context

The New York City Department of Health and Mental Hygiene publishes mid-year and annual HIV surveillance reports each year. This dataset is taken from these reports and includes data gathered from 2011 to June 30, 2016.

Content

This dataset includes HIV infections and AIDS diagnoses, viral suppression in persons living with diagnosed HIV infection (PLWDHI), deaths of those with diagnosed HIV infection, and other statistics from 2011 to 2015 in New York City boroughs.

Purpose

The data contained here shows trends in age, gender, and geographic demographics over time for HIV infections in NYC, and this can be used to visualize the prevalence of the virus in the city.

Acknowledgement

This data was pulled from NYC's OpenData at https://data.cityofnewyork.us/Health/DOHMH-HIV-AIDS-Annual-Report/fju2-rdad .

Objective: To examine if the rankings of state HIV age-standardized death rates (ASDRs) changed if different standard population (SP) was used. Design: A cross-sectional population-based observational study. Setting 36 states in the United States. Participants: People died from 2015 to 2019. Main outcome measures: State HIV ASDR using 4 SPs, namely WHO2000, US2000, US2mor020, and Eur2011–2030. Results: The rankings of 19 states did not change when ASDRs were calculated using US2000 and US2020. Of the 17 states whose rankings changed, the rankings of 9 states calculated using US2000 were higher than those calculated using US2020; in 8 states, the rankings were lower. The states with the greatest changes in rankings between US2000 and US2020 were Kentucky (12th and 9th, respectively) and Massachusetts (8th and 11th, respectively). Conclusions: State ASDRs calculated using the current official SP (US2000) weigh middle-age HIV death rates more heavily than older-age HIV death rates, resulting in lower ASDRs among states with higher older-age HIV death rates. Methods The data were extracted from CDC WONDER.

Prevalence of HIV, total (% of population ages 15-49) in United States was reported at 0.4 % in 2021, according to the World Bank collection of development indicators, compiled from officially recognized sources. United States - Prevalence of HIV, total (% of population ages 15-49) - actual values, historical data, forecasts and projections were sourced from the World Bank on July of 2025.

Between 2012 and 2021, United States of America HIV prevalence remained stable at around 0.4 %. Prevalence of HIV refers to the percentage of people ages 15-49 who are infected with HIV.

Note: ARDA – Association of Religious Data Archives; BLS – Bureau of Labor Statistics; CDC – Centers for Disease Control and Prevention; FBI – Federal Bureau of Investigation; SAMSHA N-SSATS – Substance Abuse and Mental Health Services National Survey of Substance Abuse Treatment Services. We used intercensal estimates of population aged 15–64 [66], [67].*US AIDS Mortality Surveillance Data for 1991–2006 received by special data request (2009) from the US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for HIV and TB Prevention.**Estimates of IDUs per 10,000 adult population are estimates of the proportion of the adult population who injected drugs in the prior year.***Gini coefficients are measures of the extent to which distributions of resources within a population would need to change to create equality. Zero represents equality, 1 represents maximum inequality. The household Gini used here presents data on inequality in household incomes.

Users can obtain demographic, maternal and child health, and development information regarding countries with whom UNICEF works. BackgroundUNICEF (United Nations Children Fund) is a non-governmental agency that works with governments, national and international agencies and communities to reduce the cycle of poverty in more than 150 countries and territories. UNICEF’s programs address child health and nutrition, safe water and sanitation, gender-equitable quality basic education, and the protection of children from violence, exploitation and AIDS. Topics include: country demographics, basic health, HIV/AIDS , education, and economics, among others. User Functionality Users can obtain information regarding countries with whom UNICEF works. UNICEF provides a background of each country; indicators such as country demographics, basic health, HIV/AIDS, nutrition, education, economics, child protection, women’s health and status, and rate of progress; information regarding UNICEF initiatives in the country; and news regarding current events relevant to the well-being of its residents, the impact of UNICEF and similar programs, as well as the impact of epidemics, natural disaster and political conflicts on children. Users can obtain country summaries and health indicators for each country. Maps can be downloaded as PDF files. Data Notes Data are derived from multiple sources including: UNICEF, the United Nations Population Division, United Nations Statistics Division, Joint United Nations Programme on HIV/AIDS (UNAIDS), United Nations Educational, Scientific and Cultural Organization (UNESCO), UNESCO Institute of Statistics (including Demographic Health Surveys (DHS), Multiple Indicator Cluster Surveys (MICS), Education for All 2000 Assessment), World Health Organization (WHO), Report on the Global HIV/ AIDS Epidemic, US Census Bureau, HIV/AIDS Surveillance Database, Behavioral Surveillance Surveys (BSS), Reproductive Health Surveys (RHS), International Telecommunications Union, Yearbook of Statistics, Children on the Brink, World Bank, International Monetary Fund (IMF), Organization for Economic Co-operation and Development (OECD) and national household surveys and routine reporting systems. Years to which the data apply is noted with the relevant indicator. Data updates vary according to indicator, and can be found under the “Definitions and Data Source” tab. Information is available on the country level.

United States US: Newly Infected with HIV: Children: Aged 0-14 data was reported at 200.000 Number in 2019. This stayed constant from the previous number of 200.000 Number for 2018. United States US: Newly Infected with HIV: Children: Aged 0-14 data is updated yearly, averaging 200.000 Number from Dec 2010 (Median) to 2019, with 10 observations. The data reached an all-time high of 500.000 Number in 2012 and a record low of 200.000 Number in 2019. United States US: Newly Infected with HIV: Children: Aged 0-14 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s United States – Table US.World Bank.WDI: Social: Health Statistics. Number of children (ages 0-14) newly infected with HIV.;UNAIDS estimates.;;This indicator is related to Sustainable Development Goal 3.3.1 [https://unstats.un.org/sdgs/metadata/].

This data package contains the state level HIV, tuberculosis, viral hepatitis and STD cases for the United States.

🔗 Check out my notebook here: Link

This dataset includes malnutrition indicators and some of the features that might impact malnutrition. The detailed description of the dataset is given below:

• Percentage-of-underweight-children-data: Percentage of children aged 5 years or below who are underweight by country.

• Prevalence of Underweight among Female Adults (Age Standardized Estimate): Percentage of female adults whos BMI is less than 18.

• GDP per capita (constant 2015 US$): GDP per capita is gross domestic product divided by midyear population. GDP is the sum of gross value added by all resident producers in the economy plus any product taxes and minus any subsidies not included in the value of the products. It is calculated without making deductions for depreciation of fabricated assets or for depletion and degradation of natural resources. Data are in constant 2015 U.S. dollars.

• Domestic general government health expenditure (% of GDP): Public expenditure on health from domestic sources as a share of the economy as measured by GDP.

• Maternal mortality ratio (modeled estimate, per 100,000 live births): Maternal mortality ratio is the number of women who die from pregnancy-related causes while pregnant or within 42 days of pregnancy termination per 100,000 live births. The data are estimated with a regression model using information on the proportion of maternal deaths among non-AIDS deaths in women ages 15-49, fertility, birth attendants, and GDP measured using purchasing power parities (PPPs).

• Mean-age-at-first-birth-of-women-aged-20-50-data: Average age at which women of age 20-50 years have their first child.

• School enrollment, secondary, female (% gross): Gross enrollment ratio is the ratio of total enrollment, regardless of age, to the population of the age group that officially corresponds to the level of education shown. Secondary education completes the provision of basic education that began at the primary level, and aims at laying the foundations for lifelong learning and human development, by offering more subject- or skill-oriented instruction using more specialized teachers.

Estimated HIV incidence rate, state level viral suppression and demographics by year for 29 states and the District of Columbia*.

This data package contain information of ATC (Anatomical Therapeutic Chemical) classification system. The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties. It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC), and was first published in 1976.

United States US: Children: 0-14 Living with HIV data was reported at 2,500.000 Person in 2019. This records a decrease from the previous number of 2,800.000 Person for 2018. United States US: Children: 0-14 Living with HIV data is updated yearly, averaging 3,700.000 Person from Dec 2010 (Median) to 2019, with 10 observations. The data reached an all-time high of 4,700.000 Person in 2010 and a record low of 2,500.000 Person in 2019. United States US: Children: 0-14 Living with HIV data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s United States – Table US.World Bank.WDI: Social: Health Statistics. Children living with HIV refers to the number of children ages 0-14 who are infected with HIV.;UNAIDS estimates.;;

Estimated annual percent change (EAPC) in HIV incidence rate by state with corresponding fitted annual incidence rates per 100,000.

The 2011 Uganda AIDS Indicator Survey (AIS) is a nationally representative, population-based, HIV serological survey. The survey was designed to obtain national and sub-national estimates of the prevalence of HIV and syphilis infection as well as information about other indicators of programme coverage, such as knowledge, attitudes, and sexual behaviour related to HIV/AIDS. Data collection took place from 8 February to the first few days of September 2011. The UAIS was implemented by the Ministry of Health. ICF International provided financial and technical assistance for the survey through a contract with USAID/Uganda. Financial and technical assistance was also provided by the U.S. Centers for Disease Control and Prevention (CDC). Financial support was provided by the Government of Uganda, the U.S. Agency for International Development (USAID), the President’s Emergency Fund for AIDS Relief (PEPFAR), the World Health Organisation (WHO), the UK Department for International Development (DFID), and the Danish International Development Agency (DANIDA) through the Partnership Fund. The Uganda Bureau of Statistics also partnered in the implementation of the survey. Central testing was conducted at the Uganda Virus Research Institute, with CDC conducting CD4 counts, polymerase chain reaction (PCR) testing for children, and quality control tests. The survey provided information on knowledge, attitudes, and behaviour regarding HIV/AIDS and indicators of coverage and access to other programmes, for example, HIV testing, access to antiretroviral therapy, services for treating sexually transmitted infections, and coverage of interventions to prevent motherto-child transmission of HIV. The survey also collected information on the prevalence of HIV and syphilis and their social and demographic variations in the country. The overall goal of the survey was to provide programme managers and policymakers involved in HIV/AIDS programmes with strategic information to effectively plan, implement, and evaluate HIV/AIDS interventions. The information obtained from the survey will help programme implementers to monitor and evaluate existing programmes and design new strategies for combating the HIV/AIDS epidemic in Uganda. The survey data will in addition be used to make population projections and to calculate indicators developed by the UN General Assembly Special Session (UNGASS), USAID, PEPFAR, the UNAIDS Programme, WHO, the Uganda Health Sector Strategic and Investment Plan, and the Uganda AIDS Commission. The specific objectives of the 2011 UAIS were to provide information on: • Prevalence and distribution of HIV and syphilis • Indicators of knowledge, attitudes, and behaviour related to HIV/AIDS and other sexually transmitted infections • HIV/AIDS programme coverage indicators • Levels of CD4 T-lymphocyte counts among HIV-positive adults to quantify HIV treatment needs and to calibrate model-based estimates • HIV prevalence that can be used to calibrate and improve the sentinel surveillance system • Risk factors for HIV and syphilis infections in Uganda.

Epstein-Barr virus (EBV) is transmitted by saliva and is a major cause of cancer, particularly in people living with HIV/AIDS. Here, we describe the frequency and quantity of EBV detection in the saliva of Ugandan adults with and without HIV-1 infection and use these data to develop a novel mathematical model of EBV infection in the tonsils. Eligible cohort participants were not taking antiviral medications, and those with HIV-1 infection had a CD4 count >200 cells/mm^3. Over a 4-week period, participants provided daily oral swabs that we analysed for the presence and quantity of EBV. Compared with HIV-1 uninfected participants, HIV-1 coinfected participants had an increased risk of EBV detection in their saliva (IRR=1.27, 95% CI=1.10-1.47) and higher viral loads in positive samples. We used these data to develop a stochastic, mechanistic mathematical model that describes the dynamics of EBV, infected cells, and immune response within the tonsillar epithelium to analyse potential factors that may cause EBV infection to be more severe in HIV-1 coinfected participants. The model, fit using Approximate Bayesian Computation, showed high fidelity to daily oral shedding data and matched key summary statistics. When evaluating how model parameters differed among participants with and without HIV-1 coinfection, results suggest HIV-1 coinfected individuals have higher rates of B cell reactivation, which can seed new infection in the tonsils and lower rates of an EBV-specific immune response. Subsequently, both these traits may explain higher and more frequent EBV detection in the saliva of HIV-1 coinfected individuals.